These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 17309887

  • 1. Autoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stress.
    Iwata Y, Ogawa F, Komura K, Muroi E, Hara T, Shimizu K, Hasegawa M, Fujimoto M, Tomita Y, Sato S.
    Rheumatology (Oxford); 2007 May; 46(5):790-5. PubMed ID: 17309887
    [Abstract] [Full Text] [Related]

  • 2. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
    Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
    [Abstract] [Full Text] [Related]

  • 3. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T, Ogawa F, Muroi E, Komura K, Takenaka M, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis.
    Ogawa F, Shimizu K, Muroi E, Hara T, Hasegawa M, Takehara K, Sato S.
    Rheumatology (Oxford); 2006 Jul; 45(7):815-8. PubMed ID: 16449367
    [Abstract] [Full Text] [Related]

  • 5. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
    Ogawa F, Shimizu K, Hara T, Muroi E, Komura K, Takenaka M, Hasegawa M, Fujimoto M, Takehara K, Sato S.
    Arch Dermatol Res; 2010 Jan; 302(1):27-35. PubMed ID: 19844733
    [Abstract] [Full Text] [Related]

  • 6. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I, Hasegawa M, Takehara K, Sato S.
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [Abstract] [Full Text] [Related]

  • 7. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y, Ogawa F, Iwata Y, Komura K, Muroi E, Hara T, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [Abstract] [Full Text] [Related]

  • 8. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
    Sato S, Hasegawa M, Nagaoka T, Takamatsu Y, Yazawa N, Ihn H, Kikuchi K, Takehara K.
    J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
    [Abstract] [Full Text] [Related]

  • 9. Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis.
    Nishijima C, Hayakawa I, Matsushita T, Komura K, Hasegawa M, Takehara K, Sato S.
    Clin Exp Immunol; 2004 Nov; 138(2):357-63. PubMed ID: 15498049
    [Abstract] [Full Text] [Related]

  • 10. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
    Hara T, Ogawa F, Yanaba K, Iwata Y, Muroi E, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
    [Abstract] [Full Text] [Related]

  • 11. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.
    Mimura Y, Ihn H, Jinnin M, Asano Y, Yamane K, Yazawa N, Tamaki K.
    Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420
    [Abstract] [Full Text] [Related]

  • 12. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis.
    Nishijima C, Sato S, Takehara K.
    J Rheumatol; 2001 Aug; 28(8):1847-51. PubMed ID: 11508588
    [Abstract] [Full Text] [Related]

  • 13. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J, Tremblay M, Clément I, Raymond Y, Senécal JL.
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [Abstract] [Full Text] [Related]

  • 14. Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis.
    Hasegawa M, Sato S, Yanaba K, Komura K, Yamazaki M, Takehara K.
    Ann Rheum Dis; 2004 Nov; 63(11):1514-7. PubMed ID: 15479907
    [Abstract] [Full Text] [Related]

  • 15. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis.
    Hu PQ, Fertig N, Medsger TA, Wright TM.
    Arthritis Rheum; 2003 May; 48(5):1363-73. PubMed ID: 12746909
    [Abstract] [Full Text] [Related]

  • 16. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
    Sato S, Fujimoto M, Hasegawa M, Komura K, Yanaba K, Hayakawa I, Matsushita T, Takehara K.
    Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
    [Abstract] [Full Text] [Related]

  • 17. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
    Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased serum pentraxin 3 in patients with systemic sclerosis.
    Iwata Y, Yoshizaki A, Ogawa F, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Takehara K, Sato S.
    J Rheumatol; 2009 May; 36(5):976-83. PubMed ID: 19273457
    [Abstract] [Full Text] [Related]

  • 20. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
    Komura K, Yanaba K, Ogawa F, Shimizu K, Takehara K, Sato S.
    Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.